1 Day Away From Legalization: Is it Time to Hop Off the Cannabis Hype Train?

Recreational legalization is a day away and Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) and other cannabis stocks are surging in anticipation of the big roll out.

| More on:

Cannabis stocks were one of the lone bright spots as the TSX index finished another day in the red on October 15. The cannabis sector has been on fire since August. There is a wave of excitement in the air as the official date of recreational legalization is only one day away.

Canopy Growth (TSX:WEED)(NYSE:CGC) stock surged 13.64% on October 15. Shares have climbed a stunning 95% over the past three months and the stock is up 147% in 2018 so far. Canopy Growth has consistently stood tall among the top producers due to its size, solid financials, and readiness for what is set to be a chaotic roll out.

Canopy Growth stock was also propelled by the announcement that the company had signed a deal to purchase Colorado-based hemp researcher Ebbu Inc. in a stock-and-cash deal worth more than $425 million. The company has said that this deal will help its hemp and THC-rich cannabis genetic breeding program going forward.

Aurora Cannabis (TSX:ACB) stock shot up 9.92% on the same day. Shares have surged 76% over the past month and the stock is up 56% in 2018. Aurora has managed to significantly expand its footprint in 2018; it has made waves with the two largest acquisitions in the industry’s history. There are concerns that the company has overextended itself. The company will have the opportunity to silence these critics over the course of the upcoming roll out. Aurora is also expected to be listed on the New York Stock Exchange by the end of the month.

Aphria (TSX:APH) stock moved up 4.13% on October 15. Shares are up 69% over the last three months. Aphria’s performance has been muted in comparison to its peers, as the stock is only up 6.4% in 2018 so far. However, there is reason for major optimism at Aphria going forward. It has consistently come in below its peers in production cost effectiveness and its annual production rate is expected to reach 255,000 kilograms by May 2019. Compare this to 2,700 kilograms of product sold in the first half of 2018.

Cannabis producers will now enter the “show me” period as onlookers will get to determine how well Canada can execute legalization. Investors should keep in mind that there are still major concerns for the broader industry. Early reports indicate that supply could quickly become an issue with retailers expected to see huge demand in the early weeks. Ontario, the most populous province in the country, may avoid the issue as it will only offer legal sales online until April 2019. There is speculation that the process for purchasing cannabis, which requires online identification, may deter prospective buyers.

The laws surrounding cannabis are also bound to cause some confusion early on. Some provincial governments have been openly hostile to legalization, as seen in Quebec with its draconian cannabis retail framework. This has the potential to put a cap on growth for an industry that is in such an early stage. Hopefully, Canadian producers and retailers will be able to learn and adapt to inefficiencies early on. Otherwise, it could be a long fall and winter for cannabis investors.

Fool contributor Ambrose O'Callaghan owns shares of Aurora Cannabis.

More on Investing

Concept of multiple streams of income
Dividend Stocks

Invest $10,000 in This Dividend Stock for $580 in Passive Income

There’s no shortage of passive-income investments on the market. Here’s one that can provide $580 in annual dividends.

Read more »

Silhouette of bull in front of setting sun
Investing

Invest for Tomorrow: 3 TSX Stocks to Build Lasting Wealth

These TX stocks have strong fundamentals and solid growth prospects, enabling them to deliver significant returns in the long run.

Read more »

four people hold happy emoji masks
Investing

3 TSX Stocks I Think Everyone Should Own

Let's dive into three top TSX stocks I think every long-term investor should own, each with their own unique set…

Read more »

Nurse talks with a teenager about medication
Dividend Stocks

A 6.7% Dividend Stock That Remains a Standout Buy Into 2026

NorthWest Healthcare REIT’s hospital-backed leases and improving finances make it a defensive monthly payer to consider as rates ease in…

Read more »

person on phone leaning against outside wall with scenic view at airbnb rental property
Dividend Stocks

2 Dividend Stocks I’d Gladly Buy and Hold for Life

TELUS stock's 9% dividend yield is ripe for passive income builders as the company embarks on a noble cash flow…

Read more »

a man relaxes with his feet on a pile of books
Dividend Stocks

The 1 Canadian Stock I’m Never Selling

Some stocks you buy and sell. Others you buy and earn income. Here’s one stock I’m never selling no matter…

Read more »

3 colorful arrows racing straight up on a black background.
Investing

This Stock Is Going Parabolic, and It’s Still a Buy

Quebecor (TSX:QBR.B) shares may be hot, but they're still worth picking up this winter.

Read more »

Woman checking her computer and holding coffee cup
Retirement

Here’s the Average RRSP Balance at Age 33 for Canadians

Are you behind on retirement at 33? Use an RRSP and a simple ETF like XEQT to turn small, automated…

Read more »